Caralluma fimbriata has been shown to inhibit pre-adipocyte cell division in a mouse cell study published in Food and Nutrition Sciences.
Brand name ingredient Slimaluma, an extract of Caralluma fimbriata, has been shown to inhibit pre-adipocyte cell division in a mouse cell study published in Food and Nutrition Sciences.
According to researchers, “CFE [Caralluma fimbriata extract] appears to inhibit pre-adipocyte cell division by interfering with a mechanism preceding the import of cyclin D1-CDk4/6 complex into the nucleus during the early G1 phase of the cell cycle, suggesting that CFE has the potential to inhibit hyperplastic obesity.”
They said that CFE inhibited 3T3-L1 cell growth in a dose- and duration-dependent manner, with the optimal dose appearing to be at or near 100 µm/ml. One of the researchers was Ramasamy Venkatesh of Gencor Nutrients (Anaheim, CA), the developer of Slimaluma.
CRN NY State lawsuit update: Dispatch from SupplySide East 2024
April 18th 2024CRN's Steve Mister updates Nutritional Outlook about its ongoing litigation against NY State. The organization sued the state to prevent the enforcement of law that bans sale of weight management supplements to minors.
Microalgae extract supports metabolic health and bone mass during diet and exercise routine
April 11th 2024The extract from Microphyt, called PhaeOptim, was shown to complement weight management strategies that include diet and exercise by support bone mass, aerobic capacity, resting heart rate, and blood lipid profiles.